Prestige Consumer Healthc...

86.02
1.02 (1.20%)
At close: Mar 27, 2025, 3:59 PM
86.38
0.42%
After-hours: Mar 27, 2025, 06:26 PM EDT

Company Description

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally.

The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief.

The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products.

It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels.

The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018.

Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. logo
Country United States
IPO Date Feb 10, 2005
Industry Medical - Distribution
Sector Healthcare
Employees 570
CEO Ronald M. Lombardi CPA

Contact Details

Address:
660 White Plains Road
Tarrytown, New York
United States
Website https://www.prestigebrands.com

Stock Details

Ticker Symbol PBH
Exchange NYSE
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001295947
CUSIP Number 74112D101
ISIN Number US74112D1019
Employer ID 20-1297589
SIC Code 2834

Key Executives

Name Position
Ronald M. Lombardi CPA Chairman, President & Chief Executive Officer
Christine Sacco CPA Chief Financial Officer & Chief Operating Officer
Adel Mekhail Executive Vice President of Marketing & Sales
Dean Siegal Director of Communications
Jeffrey Zerillo Senior Vice President of Operations
Mary Beth Fritz Senior Vice President of Quality & Regulatory Affairs
Philip David Terpolilli C.F.A. Director of Investor Relations
William C. P'Pool J.D. Senior Vice President, General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Mar 12, 2025 4 Filing
Mar 05, 2025 4 Filing
Feb 13, 2025 4 Filing
Feb 07, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 06, 2025 10-Q Quarterly Report
Feb 06, 2025 8-K Current Report
Jan 23, 2025 SCHEDULE 13G/A [Amend] Filing
Jan 07, 2025 4 Filing
Jan 06, 2025 8-K Current Report
Dec 10, 2024 4 Filing